TriSalus Life Sciences (TLSI) Shares Outstanding (2020 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Shares Outstanding (Entity) of $61.4 million for Q1 2026, up 90.3% year-over-year from $32.3 million in Q1 2025, and up 62.05% quarter-over-quarter from $37.9 million in Q4 2025.
TriSalus Life Sciences (TLSI) Shares Outstanding (2020 - 2026) Analysis & Trends
TriSalus Life Sciences' Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $61.4 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 90.3% year-over-year to $61.4 million; the TTM figure through Mar 2026 stood at $61.4 million (up 90.3% YoY), while the FY2025 annual figure was $37.9 million, up 49.61% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $61.4 million, up from $37.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $61.4 million in Q1 2026, with the low at $6.2 million in Q2 2023.
- The 5-year median for Shares Outstanding (Entity) is $25.3 million (2024), against an average of $27.2 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) sank 75.0% in 2023, then jumped 334.55% in 2024.
- TriSalus Life Sciences' Shares Outstanding (Entity) stood at $23.4 million in 2022, then tumbled by 59.78% to $9.4 million in 2023, then jumped by 169.61% to $25.3 million in 2024, then jumped by 49.61% to $37.9 million in 2025, then surged by 62.05% to $61.4 million in 2026.
- Business Quant data shows TLSI's Shares Outstanding (Entity) at $61.4 million in Q1 2026, $37.9 million in Q4 2025, and $49.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 97.60 Mn |
| 10 | TriSalus Life Sciences | 310.14 Mn | 263.85 Mn | 9.90 Mn | 58.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.30 Mn |
| Mar 31, 2026 | 51.54 Mn |
| Dec 31, 2025 | 37.90 Mn |
| Sep 30, 2025 | 43.06 Mn |
| Jun 30, 2025 | 32.90 Mn |
| Mar 31, 2025 | 28.53 Mn |
| Dec 31, 2024 | 25.33 Mn |
| Sep 30, 2024 | 26.50 Mn |
| Jun 30, 2024 | 23.90 Mn |
| Mar 31, 2024 | 23.32 Mn |
| Dec 31, 2023 | 9.40 Mn |
| Sep 30, 2023 | 13.17 Mn |
| Jun 30, 2023 | 5.97 Mn |
| Mar 31, 2023 | 6.25 Mn |
| Dec 31, 2022 | 23.36 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Jun 30, 2022 | 25.00 Mn |
| Mar 31, 2022 | 25.00 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Sep 30, 2021 | 25.00 Mn |